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B
ackground to the debate: In December 2004 three news 
stories in the popular press suggested that the side 
effects of  single-dose nevirapine, which has been proven 
to prevent mother-to-child transmission of HIV, had been 
covered up. Many HIV experts believed that the stories 
were unwarranted and that they would undermine use of 
the drug, leading to a rise in neonatal HIV infection. The 
controversy surrounding these stories prompted the PLoS
Medicine editors to ask health journalists, and others with an 
interest in media reporting of health, to share their views on 
the roles and responsibilities of the media in disseminating 
health information. 
Gary Schwitzer: The Agenda-Setting Role 
of Health Journalists
Some journalists say that their role and responsibility is no 
different in covering health information than it is in covering 
politics, business, or any other topic. These journalists say 
that their primary concern is accurate, clear reporting—they 
are less concerned about the consequences of their story 
once it is published [1]. But that approach may result in 
shoddy journalism and potential harm to the public [2]. I 
assert that it isn’t sufﬁ  cient to be accurate and clear when 
covering health news. Journalists have a responsibility to 
mirror a society’s needs and issues, comprehensively and 
proportionally [3]. Often that doesn’t happen in health news. 
Recently, I led an effort by the Association of Health Care 
Journalists to publish a statement of principles [4]. “Journalists 
have a special responsibility in covering health and medical 
news,” the statement reads. “Association members know that 
readers and viewers may make important health care decisions 
based on the information provided in our stories.”
In our current era of entanglement, journalists must 
investigate and report the possible conﬂ  icts of interest among 
sources of health information and those who promote a new 
idea or therapy. Such conﬂ  icts may not be readily apparent, 
so journalists must look for them as a routine part of story 
research and interviews. They must investigate and report the 
possible links between researchers and private companies, 
researchers and public institutions, patient advocacy groups 
and their sponsors, celebrity spokespersons and their 
sponsors, and nonproﬁ  t health and professional organizations 
and their sponsors. To fail to do so may mean that journalists 
become unwitting mouthpieces for incomplete, biased, and 
imbalanced news and information. 
Journalists face unique challenges in covering health news. 
Some specialized skills, knowledge, and judgment are helpful. 
For example, some information based on poorly designed 
or poorly powered studies should not be reported unless the 
ﬂ  aws are emphasized. 
Editors, reporters, and writers need to scrutinize the 
terminology used in health news. Vague, sensational terms 
(such as “cure,” “miracle,” and “breakthrough”) may harm 
news consumers by misleading and misinforming [5]. At the 
core of journalism’s values, such terms should not be used 
because they are meaningless. 
It is not the role of journalists to become advocates for 
causes. However, I believe that journalists have a responsibility 
to investigate and report on citizens’ needs as they struggle 
to understand and navigate the health-care system. People 
need help in understanding the ways in which scientists and 
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policymakers reach conclusions. In that sense, there is an 
inherent educational role that journalists must assume. 
I have a special interest in how television journalists 
cover health and health policy news. Surveys consistently 
show that many Americans get most of their health news 
and information from television. One study documented 
troubling trends of brevity (an average of 45 seconds per 
story), absence of reporter specialization, sensational claims 
not supported by data, hyperbole, commercialism, disregard 
for the uncertainty of clinical trials, baseless predictions 
of treatments based on basic science studies, single-source 
stories, and a paucity of coverage of health policy [6].
Television viewers are likely to see many more one-sided 
political ads about health policy issues than balanced, 
comprehensive news stories about such issues. In my current 
research, I am analyzing health policy news coverage on three 
award-winning TV stations in three different parts of the 
United States in 2004. Despite the fact that American voters 
ranked health care as their third leading concern (after war 
and the economy) [7], the three stations I monitored devoted 
little time to health policy issues. My analysis shows that in 
ten months (326 hours of stations’ key late night newscasts) 
on these three stations, there was only one story on the 
uninsured. Presidential candidates’ health policy platforms 
drew a combined total of seven minutes of news—an average 
of 23 seconds per story, or about 15 seconds per station per 
month of the 2004 campaign. Whether it is preclinical news 
that is not ready for prime time, or clinical news that oozes 
optimism over unproven ideas, or a disdain for health policy 
news, television journalists seem to have abdicated their 
possible agenda-setting role. 
Journalists must weigh the balance between the amount of 
attention given news about medicine and the attention given 
news about health and the social determinants of health. 
There may be too much news about the delivery of medical 
services and not enough news about the cost of, quality of, 
and evidence for those services. The current imbalance may 
contribute to the nation’s health-care cost crisis, driving 
up demand for expensive, unproven ideas. These are 
responsibilities journalists may not encounter in covering 
other topics. In health news, they are everyday issues. 
Ganapati Mudur: The Media May Be the Most 
Important Source of Health Information for the 
General Public
Health reporting does involve “telling a story,” but it also 
requires writers to take on additional responsibilities through 
the story cycle—ﬁ  nding the story, collecting information, and 
writing it.
Standard news criteria such as timeliness and impact may 
be used to pick stories. But in health reporting, context is 
crucial. Research advances to be reported need to be placed 
in context. This may be achieved by citing earlier research 
on the topic and seeking out comments from independent 
experts who could put a new ﬁ  nding in perspective. 
Sometimes health research throws up contradictory ﬁ  ndings. 
Is a gene linked to a disease? One study ﬁ  nds a link. 
Another does not. Such situations demand interpretative 
and analytical skills on the part of health writers. Otherwise, 
writers may mislead readers, or leave them confused.
Health reporters need to ﬁ  nd out who has funded the 
research and who might be likely to gain. And reporters 
must always double-check claims or else they may end up in 
embarrassing situations. Let me illustrate with an example. 
A top international science magazine last year reported 
that a novel stem cell therapy had cured patients with 
chronic aplastic anemia in Bombay, India [8]. The story was 
apparently based on claims made by the developers of the 
therapy, a private British company. A little more patience 
and investigation would have led the magazine to the real 
story: none of the patients had responded to the treatment, 
and the clinical collaborators in India had terminated the 
study [9]. 
When a public health situation is involved, health writers 
and the media can certainly play a role in quickly delivering 
important messages to the public. In a sense, then, they do 
serve as a component of the health provider community. 
And this makes it all the more important for health writers 
to ensure that they get it absolutely right. Given that most 
people do not interact with their doctors on a regular basis, 
the media is possibly the most signiﬁ  cant source of health 
information for the general public. But health information in 
the media cannot substitute for personal medical advice. It is 
important that the public understands this.
Regulatory mechanisms may be lax in some developing 
countries. India, for instance, has had a long history of 
unethical or illegal clinical trials. Drug regulatory authorities 
DOI: 10.1371/journal.pmed.0020215.g001
Journalists risk becoming unwitting mouthpieces for those with 
vested interests in their story
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in India allow the sale of drugs—including pediatric 
formulations—that have never been approved in Western 
countries. This opens up opportunities for investigative 
health journalism, an opportunity for reporters to take up 
the traditional watchdog role of the press to ﬁ  nd and report 
wrongdoing.
David Henry and Amanda Wilson: Health 
Journalists Should Discuss Beneﬁ  ts and Harms 
of New Treatments and Use Independent Expert 
Sources 
Health reporting is a major growth area for the media, 
probably because it is in demand by the public and it is 
proﬁ  table. However, media coverage of medical news is 
generally of poor quality, particularly stories about new 
treatments [10–12]. 
Media Doctor is a Web site where the quality of stories 
in the Australian press is reviewed (www.mediadoctor.org.
au). We rate articles using ten evaluation criteria (see Box 
1; www.mediadoctor.org.au/content/ratinginformation.
jsp). In February/March 2005 articles that we rated achieved 
an average of only 52% on our “satisfactory” score (www.
mediadoctor.org.au/content/sourceinfo.jsp). This was an 
improvement on the score from one year ago, but it is still 
inadequate. North American analyses of the quality of health 
reporting have had similar results [11]. The print media are 
clearly superior to the online news services [12]. The greatest 
differences between print and online services are in the use 
of independent information sources, and the quantiﬁ  cation 
of the beneﬁ  ts and the coverage of potential harms of new 
treatments.
We recognise that there are different depths of journalism 
and that journalists face constraints, including commercial 
pressures and deadlines that give little time to reﬂ  ect on 
stories, which are usually written on the same day as the 
press release arrives. Some journalists argue that the media 
are the messengers and not the message, and it is up to 
others to interpret their reporting. To a reporter who might 
otherwise exercise more caution, a well-written media release 
from a large public relations company describing a new 
pharmaceutical product must be attractive when a deadline 
is imminent. There is no danger that the company will allege 
plagiarism if it appears, almost intact, under the journalist’s 
by-line. 
And even when they do have the time, journalists face two 
major challenges—understanding the clinical science and 
epidemiology, and dealing with powerful vested interests. 
Vested interests are not unique to medicine, but reporting 
on a new drug is different from, say, an MP3 player or a 
dishwasher. People will be intensely interested in a story 
about a new drug if it purports to treat a condition that 
they or their relatives  have, and the story may become the 
basis of discussions with their physician and subsequent 
treatment decisions. We believe that in writing this type of 
story journalists have special responsibilities to ensure that 
they provide balanced information for their readers. In 
Australia, the Press Council believes the matter is of sufﬁ  cient 
importance to provide advice to journalists [13]. 
In our view journalists will meet their responsibilities if 
they cover certain key issues when writing stories about new 
medical treatments. These include the accurate reporting of 
the comparative beneﬁ  ts, harms, and costs of the treatment 
and the extent to which their informants have ties with the 
manufacturer. It is helpful if journalists use independent 
expert sources to answer questions about the novelty of the 
treatment and the availability and efﬁ  cacy of alternatives, 
although we acknowledge the practical difﬁ  culties in ﬁ  nding 
independent sources when time is limited. Journalists have 
indicated to us that they are concerned about these issues 
and are prepared to look critically at their own practices. It is 
unclear whether their editors and producers hold the same 
views and will provide the necessary resources, particularly 
time to do the job properly.
But researchers and medical journal editors have 
responsibilities too. When reading medical news stories it 
is sometimes possible to tell whether the researchers and 
journals have done a good or bad job in communicating the 
essential facts to journalists. A number of medical journals 
issue press releases, and these have been found wanting 
[14]. Researchers should consider carefully what they wish 
to convey about the results of a new study and should ask to 
see and edit any press releases. We believe the criteria used 
by Media Doctor to evaluate news stories are a good starting 
point for researchers and editors. 
Merrill Goozner: Medical Reporters Must Get 
Beyond the Hype and Hope When Reporting 
on the Latest “Breakthrough”
When I broke into the news business, the ﬁ  nancial desk’s 
primary source of breaking news was a Dow Jones wire 
clack-clack-clacking in the corner of the room. A bell rang 
whenever a major story broke. Sometimes two bells would 
go off, signaling a really big story. The day the stock market 
crashed in 1987, the newsroom sounded like St. Peters Square 
on Easter.
Box 1. Criteria Used by Media Doctor to Evaluate 
News Stories
• Whether the treatment is genuinely new 
• The availability of the treatment in Australia 
• Whether alternative treatment options are mentioned 
• If there is evidence of disease mongering in the story 
• If there is objective evidence to support the treatment 
• How the beneﬁ  ts of the treatment are framed (in relative or 
absolute terms) 
• Whether harms of the treatment are mentioned in the story 
• Whether costs of the treatment are mentioned in the story 
• Whether sources of information and any known conﬂ  icts of 
interest of informants are disclosed in the article 
• Whether the journalist relied only on the press release for the 
story
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I imagine something comparable occurs these days when 
the advance copies of leading medical journals cross science 
editors’ computer screens. Stories from the frontiers of 
medical research can make it onto page one—the most 
coveted real estate in daily journalism. News magazines have 
bolstered their sagging bottom lines with an endless stream of 
cover stories touting the latest breakthroughs in medicine.
But is this news all that it is cracked up to be? Have the 
reporters properly weighed the importance of the studies 
they’re touting? Have they asked the tough questions of the 
researchers and their sponsors to ﬁ  gure out the signiﬁ  cance 
of the results? Have they presented the data in a fashion that 
is meaningful to health-care consumers? And in an age when 
most clinical trials are sponsored by private companies, have 
they fully informed their readers of the researchers’ conﬂ  icts 
of interest?
Too often, the answer to these questions is no. Take 
recent reports from the American Society of Clinical 
Oncology, which met in mid-May in Orlando. One leading 
paper reported on a Veterans Administration review of 
the experience of over 40,000 women in the south central 
US. “The women taking statins were half as likely to have 
breast cancer as women who were not taking the drugs,” the 
paper reported [15]. Put that way, it sounds like a dramatic 
reduction. But elsewhere in the story, it was reported that 12 
percent of the women were taking the cholesterol-lowering 
medications and that only 1.4 percent of the total group 
contracted breast cancer. Only by massaging the numbers 
could one ﬁ  gure out that physicians would need to put 700 
women on statins to eliminate one cancer case (in medical 
parlance, this is called number needed to treat). It sounds a 
lot less impressive that way. But the number needed to treat 
would be a lot more meaningful to women, especially those 
on tight budgets wondering if it is worth $1,000 a year for a 
prescription.
Reporting of surrogate endpoints instead of primary 
endpoints is another way that readers get misled. Reports 
on cancer drug trials often fall into this trap. A “lifesaving” 
drug that shrinks tumors by 50 percent sounds a lot better 
than a chemotherapy agent that prolongs life by two months. 
The same can be said for bone density and fractures, blood 
pressure and strokes, and cholesterol levels and heart attacks. 
While there may be a minor yet statistically signiﬁ  cant 
reduction in the primary endpoint, the trial sponsors prefer 
to promote the more dramatic-sounding secondary endpoint. 
Too many reporters prominently feature the less meaningful 
number, while leaving out or delaying until late in the story 
the real bottom line [16].
Sadly, the media have only lately come around to taking 
seriously the issue of conﬂ  icts of interest in medical science. 
Last July, the National Heart, Lung, and Blood Institute’s 
National Cholesterol Education Project updated its guidelines 
for cholesterol management. The update, touted in the 
front page of every major US paper [17], called for a 
dramatic reduction in the cholesterol levels now considered 
optimal for people who have never had heart disease but are 
considered moderately at risk. Prescribing physicians using 
these guidelines will likely put millions more Americans on 
these drugs in the next few years.
Yet three days after the report came out, reporters at 
Newsday broke the story that eight of nine physicians on the 
National Cholesterol Education Project panel had ﬁ  nancial 
ties to statin manufacturers, which had the most to gain from 
the new guidelines. Writing in the Washington Post, former 
New England Journal of Medicine editor Jerome Kassirer asked, 
“Why should we swallow what these studies say?” [18] The 
ensuing uproar contributed to a change in policy at the New 
York Times, which last fall circulated a memo to all reporters 
encouraging them to always report conﬂ  icts of interest of 
quoted sources in science stories, a policy that leading science 
and medical journals have had in place for many years [19].
In recent years the pharmaceutical and biotechnology 
industries have responded to complaints about the high cost 
of drugs by claiming they are needed to ﬁ  nance the medical 
miracles that are just around the corner. Meanwhile, the 
increase in life expectancy in the US has slowed and still 
remains far below other advanced industrial countries. The 
number of new drugs coming out of industry labs, despite a 
slight uptick last year, is actually down from a decade ago. In a 
health-care environment that is increasingly cost-constrained, 
it shouldn’t be too much to ask that medical reporters get 
beyond the hype and hope when reporting on the latest 
“breakthrough.”
Maria Simbra: Whatever News Managers Want, 
Viewers Get—As Medical Reporters Are Pressed 
to Feed the Media Beast
Reporters are surpassing doctors as a source of medical 
information. It’s no secret health news sells. Producers and 
news directors take advantage of this to attract an audience 
for their newscasts. And viewers respond.
In a survey by Rodale Press, 39% of the respondents said 
they turn to TV for health and medical information, and 37% 
said they would ask a health professional [20].
So as audience-appointed proxies for “health professionals,” 
television medical reporters have a daunting task. They must 
be accurate, authoritative, and compassionate. They also need 
to understand the terminology, physiology, epidemiology, 
study design, and statistical analysis to keep health news in 
context for the viewer. 
But typically, this doesn’t happen. The medical industry 
churns out volumes of information for medical reporters 
to quickly sift through every day. There’s a lack of special 
training for medical journalists (the general assignment 
reporter can expect to get thrown into the medical beat 
from time to time). Usually local news reports are under 90 
seconds. The pressure for ratings compounds the problem. 
Medical news is often simpliﬁ  ed, or worse, sensationalized, 
because of industry pressures. Because health news sells, it 
can be and will be promoted—and in the process, distorted. 
What is a medical reporter to do? Well, alone, there’s not 
much a reporter can do. Like medical errors, the problems 
with medical journalism are system wide. At the root is a clash 
of cultures. 
Medicine tends to be very methodical, slow, and subject to 
change. But the media want information that’s deﬁ  nitive, they 
want it now, and, boy, it better be sensational. Also, people 
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who go into journalism and ascend to management tend to 
be more inclined toward writing and creative interests. They 
may not understand (or may be openly hostile toward) the 
scientiﬁ  c process.
For TV reporters who are committed to the medical beat, 
educational opportunities are available through organizations 
such as the Association of Health Care Journalists (www.
ahcj.umn.edu) and the National Association of Medical 
Communicators (www.ibiblio.org/namc). Journalists can 
learn how to interpret studies and present evidence-based 
balance in order to help viewers understand and make up 
their own minds about the latest developments in medicine, 
rather than just show the gee-whiz side of new technology. 
Unfortunately, it’s rare to ﬁ  nd a TV reporter who 
exclusively covers medicine. Stations view this as a luxury. It 
is more common for medical reporters to also be general-
assignment reporters or anchors, and they have other 
priorities with their combination jobs. 
It’s also rare to ﬁ  nd management that’s supportive of 
continuing education for their reporters. Even with the large 
proﬁ  t margins at many TV stations, news directors generally 
do not provide ﬁ  nancial support and ask that reporters 
interested in attending educational meetings use their 
own vacation time to  do so. Furthermore, news directors, 
producers, and promotions staff don’t seem to be themselves 
interested in learning about medical reporting.
An article in JAMA says that viewers are acting on and 
making personal medical decisions based on health 
information in the mass media [21]. This trend has led 
some TV medical reporting experts, such as Gary Schwitzer 
(formerly of CNN, now at the University of Minnesota, and 
a contributor to this PLoS Medicine debate) and Dr. Timothy 
Johnson (ABC News), to call for credentialing of medical 
journalists. After all, some meteorologists are credentialed. 
Are personal health decisions less important than the 
weather?
There’s a disconnect between what station management 
values, what the reporters need, and what the viewers get. 
Right or wrong, the audience looks to TV medical reporters 
to educate and guide them on medical issues. It’s an 
important responsibility that medical reporters and the mass 
media in general need to take seriously.
Melissa Sweet: Remember the Commercial 
Imperative When Examining Media Coverage 
of Health
Many people make the mistake of using the terms 
“journalists” and “the media” interchangeably. They speak, 
in the same breath, of the terrible failings of journalists and 
the media in covering health or other issues. In so doing, they 
fail to make a distinction between the craft or profession of 
journalism and the competitive industry that is the media. They 
fail to understand that the goals and drivers of journalism are 
often in conﬂ  ict with those of the media industry. 
The foremost goal of the media industry is, not 
surprisingly, to make proﬁ  t. Many journalists are too idealistic 
to admit, even to themselves, that their job is to make money 
for their employers. Some believe they are there for the 
public interest, or even to interest the public. Some simply 
love to tell a yarn, to get the buzz that comes with uncovering 
a great story and breaking news. Some no doubt also come 
to enjoy the reﬂ  ected glory of associating with the famous 
and the powerful. Indeed, many journalists have become 
celebrities themselves. Not coincidentally, this has beneﬁ  ts for 
their employers—nothing sells like celebrity. 
But only a brave, naïve, or foolhardy journalist would 
publicly admit these days to believing that one of their roles is 
to help provide a voice for those who otherwise have difﬁ  culty 
having their voices heard, such as the disadvantaged. It is 
not a career-enhancing move at a time when many media 
DOI: 10.1371/journal.pmed.0020215.g002
TV reporters rarely cover medicine exclusively—one day it’s ﬁ  nance, the next it’s health
(Illustration: Giovanni Maki)
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proprietors have decided that a key to improving proﬁ  ts lies 
with their so-called AB audiences.
For those not up-to-date with marketing jargon, AB is 
shorthand for the afﬂ  uent professionals so beloved by cashed-
up advertisers. The theory goes that media outlets that attract 
audiences at the AB end of the socioeconomic scale are 
more likely to win advertisers or, even better, to get away with 
charging them premium rates. A senior manager at one of 
Australia’s major newspaper groups recently explained why 
his company is focusing on boosting AB readership rather 
than total circulation [22]. “A good circulation result is one 
which attracts the readership we need and advertisers want,” 
said Mark Scott, Editor-in-Chief of Fairfax’s metropolitan 
newspapers, which include the respected broadsheet, The 
Sydney Morning Herald. 
“Sure, The Daily Telegraph [a tabloid] sells many more copies 
than The Sydney Morning Herald,” said Scott, “but their ad 
rates are lower because the SMH [Sydney Morning Herald] has 
that AB audience.” Scott said Fairfax’s Sunday title The Sun-
Herald is signiﬁ  cantly more proﬁ  table at its present circulation 
level of about 513,000 than it was when it was selling 600,000 
copies. “We have held that AB audience so our advertising 
revenue is up and our costs are lower.” 
So what has this to do with how the media report health? 
Scott explained that his newspapers do extensive market 
research so they know what the AB market wants to read and 
how they want it presented. “We create our papers with those 
readers in mind and shape our marketing and promotions 
to reinforce their values and interests.” In other words, 
the allocation of scarce resources in ever more stretched 
newsrooms is driven by what market researchers tell media 
managers about what AB audiences want to know about. 
This has implications for how the media cover all the 
areas that affect peoples’ health—politics, economics, and 
education, for example—as well as the coverage of health 
issues themselves. I haven’t seen the market research, but 
it’s not hard to guess what interests AB groups. They might 
want to know how to stay as healthy, smart, and good-looking 
as possible for as long as possible. They might want to know 
which biotech companies are good investments, and might 
be particularly interested in private health care. They are 
probably less interested in the needs of indigenous people, 
prisoners, the homeless, asylum seekers, or the poor, and it’s 
probably a fair bet to say that they are also less interested in 
the ways in which disadvantaged groups have worse access to 
health care and prevention efforts. 
Some might think this is overly cynical. Perhaps AB people 
are not all self-centred; perhaps they care about broader issues 
than those that directly affect their own lives and personal 
well-being. Nor can the compliance of journalists be assumed. 
In the chaotic and anarchic world of journalism, there are 
many who try to do far more with their jobs than to make their 
bosses wealthy—even if they have to try and “sell” their stories 
to their news managers on the grounds that the stories will 
be of interest to the ABs. Many other factors also shape and 
inﬂ  uence news production. And a truly compelling story is 
likely to get a run, even if not of direct relevance to the wealthy.
Nonetheless, it is important to remember the commercial 
imperative when examining media coverage of health. 
Many initiatives aimed at inﬂ  uencing health coverage target 
journalists, who are only one component of the media 
industry. Other powerful forces also shape how health is 
covered. An analogy can be drawn with efforts to improve the 
quality and safety of health care, another chaotic industry. 
Measures aimed at individual clinicians may be helpful in 
reducing medical errors, but it is also important to look at the 
broader system in which clinicians work.
Katherine A. Baverstock: The Media Can Play 
a Special Role in Providing a Voice for People 
to Express Their Experiences of Illness
A registered pharmacist for the last 15 years, I was trained 
in the biomedical model of health, to measure and note 
signs and symptoms, make assessments, and advise about 
treatments on the basis of available scientiﬁ  c evidence. 
Becoming interested in the portrayal of medicines in the 
media whilst working in outback Australia (which is grossly 
underserved by health professionals), I began my doctoral 
project within this quantitative biomedical tradition. As I 
found during my literature review, research arising from this 
tradition assesses media writing about medicines for “quality.” 
Such research focuses on certain categories of quantitative 
information about the medicine, such as the indication, 
associated risks and beneﬁ  ts, outcomes of treatment, 
contraindications, and cost, that would allow readers to 
analyse the evidence for themselves and decide whether they 
should use the medicine.
The research in this area seems to be advocating a position 
for the health journalist as an educator. Australia’s Quality 
Use of Medicines Strategy [23] has the objective of optimising 
the use of medicines within the Australian community. It 
lists the media as a partner in the strategy, together with 
consumers, health professionals, government, and the 
pharmaceutical industry. Similar to the other partners, the 
media have special responsibilities to ensure the quality use 
of medicines, as described in Box 2. Although many of these 
responsibilities sit comfortably within the codes of ethics 
Box 2. Australia’s National Strategy for Quality 
Use of Medicines: Responsibilities of the Media
The media are responsible for the following.
• Ethical and responsible reporting on health-care issues
• Reporting on medicines accurately and attempting to have 
errors corrected if they occur
• Being aware of the variety of available information sources on 
medicines and the limitations of each source
• Being aware of the impact of media reports on the use of 
medicines in the community
• Being aware of issues relevant to the broad context of medicine 
use, including risks of medicine use, non-drug alternatives, and 
the cost of medicine use to individuals and society
• Encouraging dissemination of messages that enhance the 
quality of medication use
Source: [23].
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observed by working journalists, some of these responsibilities 
made me uncomfortable as a health professional. Should 
journalists be viewed as de facto health educators with the 
same responsibilities as those of us in the registered health 
professions? 
As I progressed in this quantitative framework, I began 
to feel more and more uncomfortable with the narrow 
examination of the newspaper stories I had collected for 
my research. As my analysis continued, it became apparent 
that the newspaper stories contained themes far richer and 
more interesting than quantitative information about how 
drugs work. The stories were an intriguing insight into how 
the community viewed issues surrounding medicines and the 
use of medicines. Even more interesting were the narratives 
about experiences with medicines. I decided to transfer my 
research to a communications faculty, and explored a far 
different perspective of medicines in the media. One of my 
ﬁ  rst realisations was that the media are much more than the 
newspapers, television, and radio focussed on by so many 
biomedical researchers. They also include new media (the 
Internet), other print media, and small-scale media, such as 
leaﬂ  ets and posters, and even the messages on the pens given 
out by pharmaceutical representatives. 
I would like to propose that rather than act as educators, 
the media can play a special role in providing a voice for 
people to express their experiences of illness and their 
interactions with the technologies of health. The advent 
of the Internet has democratised the media because this 
medium is accessible to everyone. The Internet can cross 
national boundaries and counteract isolation—not only 
geographic isolation, but also the isolation that may be caused 
by the experience of chronic illness and not knowing anyone 
who has lived your experience. People who were unable 
to have their stories heard within the traditional medical 
consultation now have a forum where they can be heard and 
have their stories validated. 
There is much research published within the sociological 
and anthropological literature examining the narrative 
surrounding health and illness within various types of media. 
Research now needs to examine how patients use information 
they ﬁ  nd within the media, and whether it does make a 
difference to the medical encounter. Will an informed and 
questioning client leave us feeling threatened? 
Within the traditional health setting, lengthy 
communication between medical professionals and clients 
is often not possible. Many health professionals receive 
scant training in communication and counselling. The use 
of media technologies allows our clients to tell their story, 
a biography that may be ever-changing because of the 
experience of chronic illness. I would argue, that rather than 
being much maligned by health professionals, the media 
should be viewed as a tool that allows healing by facilitating 
the telling of stories. 
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